{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T18:06:12Z","timestamp":1791137172315,"version":"4.1.0"},"reference-count":58,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T00:00:00Z","timestamp":1725580800000},"content-version":"vor","delay-in-days":371,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.ymthe.2023.07.017","type":"journal-article","created":{"date-parts":[[2023,7,21]],"date-time":"2023-07-21T21:28:34Z","timestamp":1689974914000},"page":"2715-2733","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"title":["Inhibition of complement C3 signaling ameliorates locomotor and visual dysfunction in autoimmune inflammatory diseases"],"prefix":"10.1016","volume":"31","author":[{"given":"Li","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiming","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siqi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shabbir Khan","family":"Afridi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuge","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yipeng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuiqing","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiusheng","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Wen","family":"Alvin Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaxiong","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7048-108X","authenticated-orcid":false,"given":"Changyong","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2023.07.017_bib1","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/bpa.12793","article-title":"Experimental animal models of aquaporin-4-IgG-seropositive neuromyelitis optica spectrum disorders: progress and shortcomings","volume":"30","author":"Duan","year":"2020","journal-title":"Brain Pathol."},{"key":"10.1016\/j.ymthe.2023.07.017_bib2","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(04)17551-X","article-title":"A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis","volume":"364","author":"Lennon","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.ymthe.2023.07.017_bib3","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S1474-4422(12)70133-3","article-title":"Aquaporin 4 and neuromyelitis optica","volume":"11","author":"Papadopoulos","year":"2012","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.ymthe.2023.07.017_bib4","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1136\/jnnp-2016-313300","article-title":"Neurodegeneration in multiple sclerosis and neuromyelitis optica","volume":"88","author":"Kawachi","year":"2017","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.ymthe.2023.07.017_bib5","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1742-2094-5-22","article-title":"Neuromyelitis optica pathogenesis and aquaporin 4","volume":"5","author":"Graber","year":"2008","journal-title":"J.\u00a0Neuroinflammation"},{"key":"10.1016\/j.ymthe.2023.07.017_bib6","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1186\/s12974-021-02249-1","article-title":"Neuromyelitis optica spectrum disorders: from pathophysiology to therapeutic strategies","volume":"18","author":"Carnero Contentti","year":"2021","journal-title":"J.\u00a0Neuroinflammation"},{"key":"10.1016\/j.ymthe.2023.07.017_bib7","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s40265-018-1039-7","article-title":"Pharmacotherapy for Neuromyelitis Optica Spectrum Disorders: Current Management and Future Options","volume":"79","author":"Collongues","year":"2019","journal-title":"Drugs"},{"key":"10.1016\/j.ymthe.2023.07.017_bib8","doi-asserted-by":"crossref","first-page":"J276","DOI":"10.1016\/j.jaut.2009.11.014","article-title":"The complement system in systemic autoimmune disease","volume":"34","author":"Chen","year":"2010","journal-title":"J.\u00a0Autoimmun."},{"key":"10.1016\/j.ymthe.2023.07.017_bib9","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s00281-017-0644-y","article-title":"Complement as a regulator of adaptive immunity","volume":"40","author":"Killick","year":"2018","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.ymthe.2023.07.017_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2019.101340","article-title":"Complement dysregulation in the central nervous system during development and disease","volume":"45","author":"Lee","year":"2019","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.ymthe.2023.07.017_bib11","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1080\/14712598.2021.1884223","article-title":"Targeting the complement system in neuromyelitis optica spectrum disorder","volume":"21","author":"Asavapanumas","year":"2021","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1016\/j.ymthe.2023.07.017_bib12","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/j.1365-2249.2008.03830.x","article-title":"Complement in multiple sclerosis: its role in disease and potential as a biomarker","volume":"155","author":"Ingram","year":"2009","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.ymthe.2023.07.017_bib13","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/nri2620","article-title":"Complement regulators and inhibitory proteins","volume":"9","author":"Zipfel","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ymthe.2023.07.017_bib14","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1056\/NEJMoa1900866","article-title":"Eculizumab in Aquaporin-4-Positive Neuromyelitis Optica Spectrum Disorder","volume":"381","author":"Pittock","year":"2019","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2023.07.017_bib15","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/s41582-020-0400-0","article-title":"Complement in neurological disorders and emerging complement-targeted therapeutics","volume":"16","author":"Dalakas","year":"2020","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.ymthe.2023.07.017_bib16","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/imr.12500","article-title":"Complement component C3 - The \"Swiss Army Knife\" of innate immunity and host defense","volume":"274","author":"Ricklin","year":"2016","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.ymthe.2023.07.017_bib17","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1111\/imr.12470","article-title":"Injury site-specific targeting of complement inhibitors for treating stroke","volume":"274","author":"Alawieh","year":"2016","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.ymthe.2023.07.017_bib18","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.smim.2016.05.007","article-title":"New therapeutic and diagnostic opportunities for injured tissue-specific targeting of complement inhibitors and imaging modalities","volume":"28","author":"Holers","year":"2016","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.ymthe.2023.07.017_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0236968","article-title":"Complement inhibitor Crry expression in mouse placenta is essential for maintaining normal blood pressure and fetal growth","volume":"15","author":"Banadakoppa","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.ymthe.2023.07.017_bib20","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1172\/JCI17348","article-title":"Complement receptor 2-mediated targeting of complement inhibitors to sites of complement activation","volume":"111","author":"Song","year":"2003","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ymthe.2023.07.017_bib21","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1172\/JCI25208","article-title":"Targeted complement inhibition by C3d recognition ameliorates tissue injury without apparent increase in susceptibility to infection","volume":"115","author":"Atkinson","year":"2005","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ymthe.2023.07.017_bib22","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/s13287-021-02186-z","article-title":"Induced neural stem cell grafts exert neuroprotection through an interaction between Crry and Akt in a mouse model of closed head injury","volume":"12","author":"Gao","year":"2021","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.ymthe.2023.07.017_bib23","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s40478-021-01179-6","article-title":"Complement mediates neuroinflammation and cognitive decline at extended chronic time points after traumatic brain injury","volume":"9","author":"Mallah","year":"2021","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.ymthe.2023.07.017_bib24","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1016\/j.ymthe.2018.08.017","article-title":"Complement C3-Targeted Gene Therapy Restricts Onset and Progression of Neurodegeneration in Chronic Mouse Glaucoma","volume":"26","author":"Bosco","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2023.07.017_bib25","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.neulet.2012.10.012","article-title":"Targeted inhibition of complement using complement receptor 2-conjugated inhibitors attenuates EAE","volume":"531","author":"Hu","year":"2012","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ymthe.2023.07.017_bib26","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.immuni.2019.12.004","article-title":"Targeted Complement Inhibition at Synapses Prevents Microglial Synaptic Engulfment and Synapse Loss in Demyelinating Disease","volume":"52","author":"Werneburg","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.ymthe.2023.07.017_bib27","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jneuroim.2014.07.001","article-title":"Complement activation in patients with neuromyelitis optica","volume":"274","author":"Nytrova","year":"2014","journal-title":"J.\u00a0Neuroimmunol."},{"key":"10.1016\/j.ymthe.2023.07.017_bib28","first-page":"4025","article-title":"Astrocyte-microglia interaction drives evolving neuromyelitis optica lesion","volume":"130","author":"Chen","year":"2020","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ymthe.2023.07.017_bib29","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1002\/glia.22635","article-title":"Neuromyelitis optica IgG stimulates an immunological response in rat astrocyte cultures","volume":"62","author":"Howe","year":"2014","journal-title":"Glia"},{"key":"10.1016\/j.ymthe.2023.07.017_bib30","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1186\/s12974-015-0403-8","article-title":"NFkappaB signaling drives pro-granulocytic astroglial responses to neuromyelitis optica patient IgG","volume":"12","author":"Walker-Caulfield","year":"2015","journal-title":"J.\u00a0Neuroinflammation"},{"key":"10.1016\/j.ymthe.2023.07.017_bib31","doi-asserted-by":"crossref","first-page":"5956","DOI":"10.7150\/thno.33872","article-title":"Mesenchymal stem cell-derived exosomes as a nanotherapeutic agent for amelioration of inflammation-induced astrocyte alterations in mice","volume":"9","author":"Xian","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.ymthe.2023.07.017_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106814","article-title":"A complement-microglial axis driving inhibitory synapse related protein loss might contribute to systemic inflammation-induced cognitive impairment","volume":"87","author":"Li","year":"2020","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.ymthe.2023.07.017_bib33","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.expneurol.2014.12.015","article-title":"The intrinsic pathogenic role of autoantibodies to aquaporin 4 mediating spinal cord disease in a rat passive-transfer model","volume":"265","author":"Geis","year":"2015","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.ymthe.2023.07.017_bib34","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/glia.24271","article-title":"Remyelination in neuromyelitis optica spectrum disorder is promoted by edaravone through mTORC1 signaling activation","volume":"71","author":"Luo","year":"2023","journal-title":"Glia"},{"key":"10.1016\/j.ymthe.2023.07.017_bib35","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1186\/s12974-020-01913-2","article-title":"Memantine ameliorates motor impairments and pathologies in a mouse model of neuromyelitis optica spectrum disorders","volume":"17","author":"Yick","year":"2020","journal-title":"J.\u00a0Neuroinflammation"},{"key":"10.1016\/j.ymthe.2023.07.017_bib36","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1186\/s12974-019-1630-1","article-title":"Progranulin deficiency exacerbates spinal cord injury by promoting neuroinflammation and cell apoptosis in mice","volume":"16","author":"Wang","year":"2019","journal-title":"J.\u00a0Neuroinflammation"},{"key":"10.1016\/j.ymthe.2023.07.017_bib37","doi-asserted-by":"crossref","first-page":"120ra15","DOI":"10.1126\/scitranslmed.3002865","article-title":"AAV2 gene therapy readministration in three adults with congenital blindness","volume":"4","author":"Bennett","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2023.07.017_bib38","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/s41467-020-20112-4","article-title":"Transneuronal delivery of hyper-interleukin-6 enables functional recovery after severe spinal cord injury in mice","volume":"12","author":"Leibinger","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2023.07.017_bib39","doi-asserted-by":"crossref","first-page":"6911","DOI":"10.1167\/iovs.11-7434","article-title":"Latency delay of visual evoked potential is a real measurement of demyelination in a rat model of optic neuritis","volume":"52","author":"You","year":"2011","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ymthe.2023.07.017_bib40","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1167\/iovs.12-10869","article-title":"Intraocular pressure lowering is associated with an increase in the photopic negative response (PhNR) amplitude in glaucoma and ocular hypertensive eyes","volume":"54","author":"Niyadurupola","year":"2013","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ymthe.2023.07.017_bib41","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/bpa.12099","article-title":"The pathology of an autoimmune astrocytopathy: lessons learned from neuromyelitis optica","volume":"24","author":"Lucchinetti","year":"2014","journal-title":"Brain Pathol."},{"key":"10.1016\/j.ymthe.2023.07.017_bib42","doi-asserted-by":"crossref","first-page":"6551","DOI":"10.4049\/jimmunol.163.12.6551","article-title":"Central nervous system-targeted expression of the complement inhibitor sCrry prevents experimental allergic encephalomyelitis","volume":"163","author":"Davoust","year":"1999","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ymthe.2023.07.017_bib43","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1002\/ana.22551","article-title":"Ex\u00a0vivo spinal cord slice model of neuromyelitis optica reveals novel immunopathogenic mechanisms","volume":"70","author":"Zhang","year":"2011","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ymthe.2023.07.017_bib44","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/brain\/awp309","article-title":"Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice","volume":"133","author":"Saadoun","year":"2010","journal-title":"Brain."},{"key":"10.1016\/j.ymthe.2023.07.017_bib45","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nbt.1515","article-title":"Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes","volume":"27","author":"Foust","year":"2009","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2023.07.017_bib46","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.exer.2018.06.011","article-title":"Structural and visual functional deficits in a rat model of neuromyelitis optica spectrum disorders related optic neuritis","volume":"175","author":"Zhang","year":"2018","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.ymthe.2023.07.017_bib47","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1186\/s12974-016-0746-9","article-title":"Complement-independent retinal pathology produced by intravitreal injection of neuromyelitis optica immunoglobulin G","volume":"13","author":"Felix","year":"2016","journal-title":"J.\u00a0Neuroinflammation"},{"key":"10.1016\/j.ymthe.2023.07.017_bib48","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jaut.2014.05.004","article-title":"NMO spectrum of disorders: a paradigm for astrocyte-targeting autoimmunity and its implications for MS and other CNS inflammatory diseases","volume":"54","author":"Vaknin-Dembinsky","year":"2014","journal-title":"J.\u00a0Autoimmun."},{"key":"10.1016\/j.ymthe.2023.07.017_bib49","first-page":"79","article-title":"Corrigendum: Oligodendrocyte, Astrocyte and Microglia Crosstalk in Myelin Development, Damage, and Repair","volume":"4","author":"Domingues","year":"2016","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.ymthe.2023.07.017_bib50","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1186\/s12974-018-1292-4","article-title":"Complement activation contributes to perioperative neurocognitive disorders in mice","volume":"15","author":"Xiong","year":"2018","journal-title":"J.\u00a0Neuroinflammation"},{"key":"10.1016\/j.ymthe.2023.07.017_bib51","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1523\/JNEUROSCI.2117-15.2016","article-title":"Astrocyte-Microglia Cross Talk through Complement Activation Modulates Amyloid Pathology in Mouse Models of Alzheimer's Disease","volume":"36","author":"Lian","year":"2016","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.ymthe.2023.07.017_bib52","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.3389\/fimmu.2018.01753","article-title":"The Kaleidoscope of Microglial Phenotypes","volume":"9","author":"Dubbelaar","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymthe.2023.07.017_bib53","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1146\/annurev-immunol-051116-052358","article-title":"Microglia Function in the Central Nervous System During Health and Neurodegeneration","volume":"35","author":"Colonna","year":"2017","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.ymthe.2023.07.017_bib54","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.161003","article-title":"T follicular helper cells contribute to pathophysiology in a model of neuromyelitis optica spectrum disorders","volume":"8","author":"Yick","year":"2023","journal-title":"JCI Insight"},{"key":"10.1016\/j.ymthe.2023.07.017_bib55","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/nature14335","article-title":"Drug-based modulation of endogenous stem cells promotes functional remyelination in\u00a0vivo","volume":"522","author":"Najm","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2023.07.017_bib56","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1038\/nprot.2010.128","article-title":"A semiautomated targeted sampling method to assess optic nerve axonal loss in a rat model of glaucoma","volume":"5","author":"Marina","year":"2010","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ymthe.2023.07.017_bib57","first-page":"1380","article-title":"Patterns of intraocular pressure elevation after aqueous humor outflow obstruction in rats","volume":"41","author":"Jia","year":"2000","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ymthe.2023.07.017_bib58","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001623003970?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001623003970?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T18:09:13Z","timestamp":1761502153000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001623003970"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":58,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S1525001623003970"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2023.07.017","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of complement C3 signaling ameliorates locomotor and visual dysfunction in autoimmune inflammatory diseases","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2023.07.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}]}}